Читать книгу Fundamentals of Fixed Prosthodontics - James C. Kessler - Страница 27

1. The Glossary of Prosthodontic Terms. J Prosthet Dent 2005;94: 10–92.

2. American Dental Association. Current Dental Terminology (CDT 2007–2008). Eden Prairie, MN: Ingenix, 2006:47.

3. Ciancio SC. Medications’ impact on oral health. J Am Dent Assoc 2004;135:1440–1448.

4. Bent S, Ko R. Commonly used herbal medications in the United States: A review. Am J Med 2004;116:478–485.

5. Hajjar I, Kotchen TA. Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988– 2000. JAMA 2003;290:199–206.

6. Herman WW, Konzelman JL Jr, Prisant LM; Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. New national guidelines on hypertension: A summary for dentistry. J Am Dent Assoc 2004;135:576–584.

7. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R, Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: A meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002;360:1903–1913 [erratum 2003;361:1060].

8. Glick M. The new blood pressure guidelines—A digest. J Am Dent Assoc 2004;135:585–586.

9. Arauz-Pacheco C, Parrott MA, Raskin P; American Diabetes Association. Treatment of hypertension in adults with diabetes. Diabetes Care 2003;26(suppl 1):S80–S82.

10. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Am J Kidney Dis 2002;39(2 suppl 1):Sl–S266.

11. Rose LF, Mealey B, Minsk L, Cohen DW. Oral care for patients with cardiovascular disease and stroke. J Am Dent Assoc 2002; 133(suppl):37S–44S.

12. Herman WW, Konzelman JL, Sutley SH. Current perspectives on dental patients receiving coumarin anticoagulant therapy. J Am Dent Assoc 1997;128:327–335.

13. Jeske AH, Suchko GD; ADA Council on Scientific Affairs and Division of Science, Journal of the American Dental Association. Lack of a scientific basis for routine discontinuation of oral anticoagulant therapy before dental treatment. J Am Dent Assoc 2003;134:1492–1497 [erratum 2004;135:28].

14. Hirsh J, Dalen JE, Deykin D, Poller L. Oral anticoagulants: Mechanism of action, clinical effectiveness, and optimal therapeutic range. Chest 1992;102(4 suppl):312S–326S.

15. Hirsh J, Fuster V. Guide to anticoagulant therapy. Part 2: Oral anticoagulants. American Heart Association. Circulation 1994;89: 1469–1480.

16. Cannegieter SC, Rosendaal MD, Briët E. Thromboembolic and bleeding complications in patients with mechanical heart valve prostheses. Circulation 1994;89:635–641.

17. Wahl MJ. Myths of dental surgery in patients receiving anticoagulant therapy. J Am Dent Assoc 2000;131:77–81.

18. Scully C, Wolff A. Oral surgery in patients on anticoagulant therapy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2002;94:57–64.

19. Wilson W, Taubert KA, Gewitz M, et al. Prevention of infective endocarditis: Guidelines from the American Heart Association: A guideline from the American Heart Association Rheumatic Fever, Endocarditis and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group. J Am Dent Assoc 2007;138:739–760.

20. Tong DC, Rothwell BR. Antibiotic prophylaxis in dentistry: A review and practice recommendations. J Am Dent Assoc 2000; 131:366–374.

21. Brackett SE. Infective endocarditis and mitral valve prolapse— The unsuspected risk. A case report. Oral Surg Oral Med Oral Pathol 1982;54:273–276.

22. Miller CS, Egan RM, Falace DA, Rayens MK, Moore CR. Prevalence of infective endocarditis in patients with systemic lupus erythematosis. J Am Dent Assoc 1999;130:387–392.

23. Lessard E, Glick M, Ahmed S, Saric M. The patient with a heart murmur: Evaluation, assessment and dental considerations. J Am Dent Assoc 2005;136:347–356.

24. American Dental Association, American Academy of Orthopedic Surgeons. Antibiotic prophylaxis for dental patients with total joint replacements. J Am Dent Assoc 2003;134:895–899.

25. Glick M. Diabetes: It is all about the numbers [editorial]. J Am Dent Assoc 2006;137:12,14.

26. Shlossman M, Knowler WC, Pettitt DJ, Genco RJ. Type 2 diabetes mellitus and periodontal disease. J Am Dent Assoc 1990;121:532–536.

27. Vernillo AT. Dental considerations for the treatment of patients with diabetes mellitus. J Am Dent Assoc 2003;134(special issue): 24S–33S.

28. American Diabetes Association. Standards of medical care in diabetes—2007. Diabetes Care 2007;30(suppl 1):S4–S41.

29. Nathan DM, Kuenen J, Borg R, et al. Translating the A1C assay into estimated average glucose values. Diabetes Care 2008; 31:1473–1478 [erratum 2009;32:207].

30. Kahn R, Fonseca V. Translating the A1C assay. Diabetes Care 2008;31:1704–1707.

31. Frank RM, Herdly J, Philipe E. Acquired dental defects and salivary gland lesions after irradiation for carcinoma. J Am Dent Assoc 1965;70:868–883.

32. Bertram U. Xerostomia. Clinical aspects, pathology and pathogenesis. Acta Odontol Scand 1967;25(suppl 49):1–126.

33. Daniels T, Silverman S, Michalski JP, Greenspan JS, Sylvester RA, Talal N. The oral component of Sjögren’s syndrome. Oral Surg Oral Med Oral Pathol 1975;39:875–885.

34. Al-Hashimi I. The management of Sjögren’s syndrome in dental practice. J Am Dent Assoc 2001;132:1409–1417.

35. Sreebny LM, Schwartz SS. A reference guide to drugs and dry mouths. Gerodontology 1986;5:75–99.

36. Guttenberg SA. Bisphosphonates and bone . . . What have we learned? [editorial] Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2008;106:769–772.

37. Ruggiero SL, Fantasia J, Carlson E. Bisphosphonate-related osteonecrosis of the jaw: Background and guidelines for diagnosis, staging and management. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006;102:433–441.

38. Hess LM, Jeter JM, Benham-Hutchins M, Alberts DS. Factors associated with osteonecrosis of the jaw among bisphosphonate users. Am J Med 2008;121:475–483.

39. Marx RE, Sawatari Y, Fortin M, Broumand V. Bisphosphonateinduced exposed bone (osteonecrosis/osteopetrosis) of the jaws: Risk factors, recognition, prevention, and treatment. J Oral Maxillofac Surg 2005;63:1567–1575.

40. Sedghizadeh PP, Stanley K, Caligiuri M, Hofkes S, Lowry B, Shuler CF. Oral bisphosphonate use and the prevalence of osteonecrosis of the jaw: An institutional inquiry. J Am Dent Assoc 2009;140:61–66.

41. Scully C, Madrid C, Bagan J. Dental endosseous implants in patients on bisphosphonate therapy. Implant Dent 2006;15:212– 218.

42. Wright EF. Referred craniofacial pain patterns in patients with temporomandibular disorder. J Am Dent Assoc 2000;131:1307– 1315 [erratum 2000;131:1553].

43. Tallents RH, Hatala M, Katzberg RW, Westesson PL. Temporomandibular joint sounds in asymptomatic volunteers. J Prosthet Dent 1993;69:298–304.

44. US Department of Labor, US Department of Health and Human Services. Joint Advisory Notice: Protection Against Occupational Exposure to Hepatitis B Virus (HBV) and Human Immunodeficiency Virus (HIV). Washington, DC: US Department of Labor, US Department of Health and Human Services, 1987.

45. Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic diseases. Centers for Disease Control and Prevention. MMWR Recomm Rep 1998;47(RR-19):1–39.

46. Centers for Disease Control and Prevention. Viral Hepatitis. http://www.cdc.gov/hepatitis/. Accessed 10 Apr 2009.

47. Mast EE, Weinbaum CM, Fiore AE, et al. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: Recommendation of the Advisory Committee on Immunization Practices (ACIP). Part II: Immunization of adults. MMWR Recomm Rep 2006;55(RR-16):1–33 [erratum MMWR Morb Mortal Wkly Rep 2007;56:1114].

48. Centers for Disease Control. Hepatitis B virus vaccine safety: Report of an inter-agency group. MMWR 1982;31:465–467.

49. Centers for Disease Control. The safety of hepatitis B virus vaccine. MMWR 1983;32:134–136.

50. Infection control recommendations for the dental office and the dental laboratory. Council on Dental Materials, Instruments and Equipment. Council on Dental Practice. Council on Dental Therapeutics. J Am Dent Assoc 1988;116:241–248 [erratum 1988;116:614].

51. National Board for Certification of Dental Laboratories. Infection Control Requirements for Certified Dental Laboratories. Alexandria, VA: National Association of Dental Laboratories, 1986.